Shelly Brands, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 993 Brodhead Rd, Moon Township, PA 15108 Phone: 412-474-3566 |
Courtney Lynn Heberling, MS.-CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 993 Brodhead Road, Suite 203, Moon Township, PA 15108 Phone: 412-474-3566 Fax: 412-474-3575 |
Anita Lacenere, M.A.CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 951 Brodhead Rd, Moon Township, PA 15108 Phone: 412-583-2980 |
News Archive
It's a popularly held belief that individuals with an autism spectrum disorder (ASD) gravitate toward STEM majors in college (science, technology, engineering mathematics).
Tolerx, Inc. and GlaxoSmithKline (GSK) today announced that the Phase 3 DEFEND-1 study of otelixizumab, an investigational humanized anti-CD3 monoclonal antibody, did not meet the primary efficacy endpoint of change in C-peptide at month 12 in patients with new-onset autoimmune type 1 diabetes.
Bayer HealthCare Pharmaceuticals Inc. and Onyx Pharmaceuticals, Inc., an Amgen subsidiary (Nasdaq: AMGN), today announced that a Phase 3 trial evaluating the investigational use of NEXAVAR® (sorafenib) tablets as an adjuvant treatment for patients with hepatocellular carcinoma (HCC), or liver cancer, who had no detectable disease after surgical resection or local ablation, did not meet its primary endpoint of improving recurrence-free survival.
The Wall Street Journal profiles the case of a man infected with extensively drug-resistant tuberculosis (XDR-TB) who is being detained in South Texas after a "three-month odyssey through 13 countries - from his homeland of Nepal through South Asia, Brazil, Mexico, and finally into Texas - show[ing] the way in which dangerous new strains of the disease can migrate across the world unchecked."
Kaiser Health News provides a fresh take on health policy developments with "I Am Your Father" by Jerry King.
› Verified 7 days ago